Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mittal

Showing results (231-240 of 265) with videos related to

Pageof 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trialEzra E W Cohen, Daniel J Haraf, Marcy A List, et al.
Journal of Muscle Research and Cell Motility|October 1, 1996
The myosin filament XV assembly: contributions of 195 residue segments of the myosin rod and the eight C-terminal residuesP K Chowrashi, S M Pemrick, S Li, et al.
Archives of Dermatological Research|November 18, 2020
Core outcome sets and core outcome measures: a primerMurad Alam, Sarah A Ibrahim, Bianca Y Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancerE E Vokes, M S Kies, D J Haraf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancerFred R Rosen, Daniel J Haraf, Merrill S Kies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphomaA M Evens, J K Altman, B B Mittal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Predictors of competing mortality in advanced head and neck cancerLoren K Mell, James J Dignam, Joseph K Salama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experienceB Brockstein, D J Haraf, A W Rademaker, et al.
Journal of the American Academy of Dermatology|May 15, 2023
Minimum thresholds deemed acceptable by patients and physicians for sensitivity and specificity of mobile skin cancer screening algorithmsNoor Anvery, Bianca Kang, Rachel E Christensen, et al.
Frontiers in Immunology|January 8, 2025
Ionizing radiation improves skin bacterial dysbiosis in cutaneous T-cell lymphomaLauren P Chrisman, Yanzhen Pang, Madeline J Hooper, et al.
Pageof 27

Showing results (231-240 of 265) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trialEzra E W Cohen, Daniel J Haraf, Marcy A List, et al.
Journal of Muscle Research and Cell Motility|October 1, 1996
The myosin filament XV assembly: contributions of 195 residue segments of the myosin rod and the eight C-terminal residuesP K Chowrashi, S M Pemrick, S Li, et al.
Archives of Dermatological Research|November 18, 2020
Core outcome sets and core outcome measures: a primerMurad Alam, Sarah A Ibrahim, Bianca Y Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancerE E Vokes, M S Kies, D J Haraf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancerFred R Rosen, Daniel J Haraf, Merrill S Kies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphomaA M Evens, J K Altman, B B Mittal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Predictors of competing mortality in advanced head and neck cancerLoren K Mell, James J Dignam, Joseph K Salama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experienceB Brockstein, D J Haraf, A W Rademaker, et al.
Journal of the American Academy of Dermatology|May 15, 2023
Minimum thresholds deemed acceptable by patients and physicians for sensitivity and specificity of mobile skin cancer screening algorithmsNoor Anvery, Bianca Kang, Rachel E Christensen, et al.
Frontiers in Immunology|January 8, 2025
Ionizing radiation improves skin bacterial dysbiosis in cutaneous T-cell lymphomaLauren P Chrisman, Yanzhen Pang, Madeline J Hooper, et al.
Pageof 27